SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
30-Aug-21 5:16 PM View: | Prelude Therapeutics Inc (PRLD) | 27-Aug-21 | Option Exercise | 6,014 | $1.43 | $8,600.02 | 3% 172.92K to 178.93K | |
30-Aug-21 5:16 PM View: | Prelude Therapeutics Inc (PRLD) | 27-Aug-21 | Market Option Sale (Planned) | 6,014 | $35.91 | $215,967.00 | (3%) 178.93K to 172.92K | |
30-Aug-21 5:16 PM View: | Prelude Therapeutics Inc (PRLD) | 26-Aug-21 | Option Exercise | 1,700 | $1.43 | $2,431.00 | < 1% 172.92K to 174.62K | |
30-Aug-21 5:16 PM View: | Prelude Therapeutics Inc (PRLD) | 26-Aug-21 | Market Option Sale (Planned) | 1,700 | $35.19 | $59,819.40 | (< 1%) 174.62K to 172.92K | |
17-Aug-21 4:44 PM View: | Prelude Therapeutics Inc (PRLD) | 13-Aug-21 | Option Exercise | 2,286 | $1.54 | $3,525.66 | 1% 172.92K to 175.21K | |
17-Aug-21 4:44 PM View: | Prelude Therapeutics Inc (PRLD) | 13-Aug-21 | Market Option Sale (Planned) | 2,286 | $35.07 | $80,161.30 | (1%) 175.21K to 172.92K | |
29-Jul-21 7:27 PM View: | Prelude Therapeutics Inc (PRLD) | 27-Jul-21 | Option Exercise | 20,000 | $1.43 | $28,600.00 | 12% 172.92K to 192.92K | |
29-Jul-21 7:27 PM View: | Prelude Therapeutics Inc (PRLD) | 27-Jul-21 | Market Option Sale (Planned) | 20,000 | $35.47 | $709,380.00 | (10%) 192.92K to 172.92K | |
11-May-21 6:46 PM View: | Prelude Therapeutics Inc (PRLD) | 07-May-21 | Option Exercise | 10,000 | $1.43 | $14,300.00 | 6% 172.92K to 182.92K | |
11-May-21 6:46 PM View: | Prelude Therapeutics Inc (PRLD) | 07-May-21 | Market Option Sale (Planned) | 10,000 | $40.82 | $408,192.00 | (5%) 182.92K to 172.92K | |
15-Apr-21 7:14 PM View: | Prelude Therapeutics Inc (PRLD) | 08-Apr-21 | Grant | 4,630 | $1.43 | $6,620.90 | 3% 172.92K to 177.55K | |
15-Apr-21 7:14 PM View: | Prelude Therapeutics Inc (PRLD) | 08-Apr-21 | Market Sale (Planned) | 4,630 | $38.34 | $177,504.00 | (3%) 177.55K to 172.92K | |
09-Apr-21 5:55 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Apr-21 | Grant | 15,370 | $1.43 | $21,979.10 | 9% 172.92K to 188.29K | |
09-Apr-21 5:55 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Apr-21 | Market Sale (Planned) | 15,370 | $39.31 | $604,144.00 | (8%) 188.29K to 172.92K |